This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Exploring Current Metastatic Colorectal Cancer (mCRC) Treatment Options

Exploring Current Metastatic Colorectal Cancer (mCRC) Treatment Options

Format

Webcast

Time to Complete

1.50 hours

Released

May 31, 2018

Expires

May 31, 2019
Add to Queue


Maximum Credits

1.50 / AMA PRA Category 1 Credit(s)TM
1.30 / CNE Contact Hours
1.50 / CE for Pharmacists (0.15 CEUs)

Accredited Provider

Jointly provided by Postgraduate Institute for Medicine and MedInsights CE Academy.

Commercial Supporter

Supported by an independent educational grant from Taiho Oncology

Program Description

The single-session, web-based CME activity will provide learners with current evidence-based best practice guidelines and medical knowledge in the treatment of metastatic colorectal cancer (mCRC). Participants will also learn strategies to manage patient communication and ways to work effectively within an interprofessional team to improve outcomes.

Intended Audience

Oncology physicians, nurse practitioners, physician assistants, pharmacists, and registered nurses

Educational Objectives

After completing this activity, participants should be better able to:

  • List NCCN treatment guidelines for first, second and third line therapies for mCRC patients
  • Describe the risks associated with an ageist approach to care of geriatric patients with mCRC and how to avoid this approach
  • Explain how RAS, BRAF and MSI testing plays a part in developing the most appropriate treatment plans
  • Discuss primary and acquired treatment resistance and current evidence based treatment options for resistant mCRC
  • Outline strategies to improve communication and education for patients with mCRC
  • Identify jargon which may be confusing to patients and the importance of clear communication with patients about their treatment goals and prognosis

Conflicts of Interest Disclosure Policy

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

Faculty

John Marshall, MD
Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital
Professor of Medicine and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University
Director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer


Dr. Marshall discloses the following:
Consulting Fees & Fees for Non-CME/CE Services Received Directly from a Commercial Interest: Genentech, Amgen, Bayer, Celgene, Caris, Taiho

Cathy Eng, MD
Professor
Department of Gastrointestinal (GI) Medical Oncology
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX


Dr. Eng discloses the following:
Consulting Fees: Genentech, Bayer.
Contracted Research: Roche, Forty-Seven, Inc.

Planners and Managers

The PIM planners and managers have nothing to disclose. The MedInsights CE Academy planners and managers have nothing to disclose.

Credit

1.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedInsights CE Academy.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The Postgraduate Institute for Medicine designates this enduring material activity for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM .   Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.30

Type

CNE Contact Hour(s)

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedInsights CE Academy.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

The maximum number of hours awarded for this Continuing Nursing Education activity is 1.30 contact hour(s).

Credit

1.50

Type

CE for Pharmacists

Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MedInsights CE Academy.  Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Designation Statement

Postgraduate Institute for Medicine designates this continuing education activity for 1.50 contact hour(s) (0.15 CEUs) of the Accreditation Council for Pharmacy Education. Activity type: Knowledge.

ACPE UAN: JA-4008162-9999-18-157-H04-P

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 75% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Postgraduate Institute for Medicine at: inquiries@pimed.com or (303) 799-1930.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue